572 related articles for article (PubMed ID: 15918160)
1. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.
Pearson EC; Woosley RL
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):747-53. PubMed ID: 15918160
[TBL] [Abstract][Full Text] [Related]
2. Torsades de pointes with methadone.
Prescrire Int; 2005 Apr; 14(76):61-2. PubMed ID: 15875343
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
Aström-Lilja C; Odeberg JM; Ekman E; Hägg S
Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):587-92. PubMed ID: 18449951
[TBL] [Abstract][Full Text] [Related]
4. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.
Perrin-Terrin A; Pathak A; Lapeyre-Mestre M
Fundam Clin Pharmacol; 2011 Aug; 25(4):503-10. PubMed ID: 20825488
[TBL] [Abstract][Full Text] [Related]
5. [Routine ECG in methadone-assisted rehabilitation is wrong prioritization].
Krook AL; Waal H; Hansteen V
Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2940-1. PubMed ID: 15550974
[TBL] [Abstract][Full Text] [Related]
6. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions.
Wysowski DK; Corken A; Gallo-Torres H; Talarico L; Rodriguez EM
Am J Gastroenterol; 2001 Jun; 96(6):1698-703. PubMed ID: 11419817
[TBL] [Abstract][Full Text] [Related]
7. Droperidol, QT prolongation, and sudden death: what is the evidence?
Kao LW; Kirk MA; Evers SJ; Rosenfeld SH
Ann Emerg Med; 2003 Apr; 41(4):546-58. PubMed ID: 12658255
[TBL] [Abstract][Full Text] [Related]
8. Methadone-induced torsade de pointes in a patient with normal baseline QT interval.
Almehmi A; Malas AM; Yousufuddin M; Rosencrance JG
W V Med J; 2004; 100(4):147-8. PubMed ID: 15471174
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors.
Ehret GB; Voide C; Gex-Fabry M; Chabert J; Shah D; Broers B; Piguet V; Musset T; Gaspoz JM; Perrier A; Dayer P; Desmeules JA
Arch Intern Med; 2006 Jun; 166(12):1280-7. PubMed ID: 16801510
[TBL] [Abstract][Full Text] [Related]
10. QTc prolongation and torsades de pointes associated with methadone therapy.
Routhier DD; Katz KD; Brooks DE
J Emerg Med; 2007 Apr; 32(3):275-8. PubMed ID: 17394991
[TBL] [Abstract][Full Text] [Related]
11. Methadone-associated QT prolongation and torsades de pointes. Dubrey and Groscott-Mason's patient was underttreated for her atrial fibrillation.
Al-Sardar H
Br J Hosp Med (Lond); 2007 Apr; 68(4):221; author reply 221. PubMed ID: 17469230
[No Abstract] [Full Text] [Related]
12. A case series of drug-induced long QT syndrome and Torsade de Pointes.
Tong KL; Lau YS; Teo WS
Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
[TBL] [Abstract][Full Text] [Related]
13. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?
Nuttall GA; Eckerman KM; Jacob KA; Pawlaski EM; Wigersma SK; Marienau ME; Oliver WC; Narr BJ; Ackerman MJ
Anesthesiology; 2007 Oct; 107(4):531-6. PubMed ID: 17893447
[TBL] [Abstract][Full Text] [Related]
14. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
15. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D
J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced torsades de pointes in patients aged 80 years or more.
Paran Y; Mashav N; Henis O; Swartzon M; Arbel Y; Justo D
Anadolu Kardiyol Derg; 2008 Aug; 8(4):260-5. PubMed ID: 18676301
[TBL] [Abstract][Full Text] [Related]
17. Methadone-associated Torsades de Pointes (polymorphic ventricular tachycardia) in opioid-dependent patients.
Justo D; Gal-Oz A; Paran Y; Goldin Y; Zeltser D
Addiction; 2006 Sep; 101(9):1333-8. PubMed ID: 16911733
[TBL] [Abstract][Full Text] [Related]
18. Torsade de pointes induced by systemic antifungal agents: lessons from a retrospective analysis of published case reports.
Justo D; Zeltser D
Mycoses; 2006 Nov; 49(6):463-70. PubMed ID: 17022762
[TBL] [Abstract][Full Text] [Related]
19. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
Arbel Y; Swartzon M; Justo D
Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
[TBL] [Abstract][Full Text] [Related]
20. Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient.
Nair MK; Patel K; Starer PJ
Addiction; 2008 Dec; 103(12):2062-4. PubMed ID: 19469750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
